3.Lancet T. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet, 1997, 349(9065):1569-1581.
4.CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke. Lancet, 1997, 349(9066):1641-1649.
5.Hollopeter G, Jantzen H M, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature, 2001, 409(6817):202-207.
6.Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. International Journal of Clinical Practice, 1996, 51(4):205-208.
7. Curran MP, Keating GM. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs. 2005;65(14):2009-2035.